1. Ioacara, S., Popescu, A. C., Tenenbaum, J., Dimulescu, D. R., Popescu, M. R., Sirbu, A., et al. (2020). Acute myocardial infarction mortality rates and trends in Romania between 1994 and 2017. International Journal of Environmental Research and Public Health, 17(1), 285.
2. Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., et al. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the global burden of disease study 2017. The Lancet, 392(10159), 1736–1788.
3. Wei, H., Li, H., Wan, S. P., Zeng, Q. T., Cheng, L. X., Jiang, L. L., et al. (2017). Cardioprotective effects of Malvidin against isoproterenol-induced myocardial infarction in rats: A mechanistic study. Medical Science Monitor, 23, 2007–2016.
4. Chew, D. S., Heikki, H., Schmidt, G., Kavanagh, K. M., Dommasch, M., Bloch Thomsen, P. E., et al. (2018). Change in left ventricular ejection fraction following first myocardial infarction and outcome. JACC: Clinical Electrophysiology, 4(5), 672–682.
5. Miller, A. L., Dib, C., Li, L., Chen, A. Y., Amsterdam, E., Funk, M., et al. (2012). Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use. Circulation: Cardiovascular Quality and Outcomes, 5(5), 662–671.